Cipla Lines Up Advair But Costs Will Flatten High-Value Launches

Higher R&D Costs And Market-Driven Inflation Expected In 2022/23

 
• By Dean Rudge
  
Sergei Babenko/Alamy Stock Photo
How profitable will the planned Advair Gx be? • Source: Shutterstock (Sergei Babenko / Alamy Stock Pho/Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business